Ligand coupling mechanism of the human serotonin transporter differentiates substrates from inhibitors
Abstract The presynaptic serotonin transporter (SERT) clears extracellular serotonin following vesicular release to ensure temporal and spatial regulation of serotonergic signalling and neurotransmitter homeostasis. Prescription drugs used to treat neurobehavioral disorders, including depression, an...
Main Authors: | Ralph Gradisch, Katharina Schlögl, Erika Lazzarin, Marco Niello, Julian Maier, Felix P. Mayer, Leticia Alves da Silva, Sophie M. C. Skopec, Randy D. Blakely, Harald H. Sitte, Marko D. Mihovilovic, Thomas Stockner |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-44637-6 |
Similar Items
-
Structural basis of organic cation transporter-3 inhibition
by: Basavraj Khanppnavar, et al.
Published: (2022-11-01) -
Determining Ligand and Ion-Induced Conformational Changes in Serotonin Transporter with Its Fluorescent Substrates
by: Mu Li, et al.
Published: (2022-09-01) -
Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1–3 and Human Plasma Membrane Monoamine Transporter
by: Thomas J. F. Angenoorth, et al.
Published: (2021-11-01) -
Functional and pathological consequences of being fast on the uptake: Protein kinase G and p38α MAPK regulation of serotonin transporters
by: Paula A. Gajeswski-Kurdziel, et al.
Published: (2024-01-01) -
Handling of intracellular K+ determines voltage dependence of plasmalemmal monoamine transporter function
by: Shreyas Bhat, et al.
Published: (2021-06-01)